beta-eudesmol has been researched along with calcimycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, SH; Jeong, HJ; Kang, TH; Kim, HM; Kim, SJ; Rim, HK; Seo, MJ; Um, JY | 1 |
1 other study(ies) available for beta-eudesmol and calcimycin
Article | Year |
---|---|
The regulatory mechanism of β-eudesmol is through the suppression of caspase-1 activation in mast cell-mediated inflammatory response.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Calcimycin; Caspase Inhibitors; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Cellular; Interleukin-6; Mast Cells; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes, Eudesmane; Tetradecanoylphorbol Acetate | 2011 |